These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33979722)

  • 1. Internet-based cognitive assessment tool: Sensitivity and validity of a new online cognition screening tool for patients with bipolar disorder.
    Miskowiak KW; Jespersen AE; Obenhausen K; Hafiz P; Hestbæk E; Gulyas L; Kessing LV; Bardram JE
    J Affect Disord; 2021 Jun; 289():125-134. PubMed ID: 33979722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Internet-Based Cognitive Assessment Tool: System Design and Feasibility Study.
    Hafiz P; Miskowiak KW; Kessing LV; Elleby Jespersen A; Obenhausen K; Gulyas L; Zukowska K; Bardram JE
    JMIR Form Res; 2019 Jul; 3(3):e13898. PubMed ID: 31350840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising screening for cognitive dysfunction in bipolar disorder: Validation and evaluation of objective and subjective tools.
    Jensen JH; Støttrup MM; Nayberg E; Knorr U; Ullum H; Purdon SE; Kessing LV; Miskowiak KW
    J Affect Disord; 2015 Nov; 187():10-9. PubMed ID: 26301477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norms for the Screen for Cognitive Impairment in Psychiatry and cognitive trajectories in bipolar disorder.
    Ott CV; Knorr U; Jespersen A; Obenhausen K; Røen I; Purdon SE; Kessing LV; Miskowiak KW
    J Affect Disord; 2021 Feb; 281():33-40. PubMed ID: 33285390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for cognitive dysfunction in unipolar depression: Validation and evaluation of objective and subjective tools.
    Ott CV; Bjertrup AJ; Jensen JH; Ullum H; Sjælland R; Purdon SE; Vieta E; Kessing LV; Miskowiak KW
    J Affect Disord; 2016 Jan; 190():607-615. PubMed ID: 26583350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP).
    Cuesta MJ; Pino O; Guilera G; Rojo JE; Gómez-Benito J; Purdon SE; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Crespo-Facorro B; Mesa F; Rejas J
    Schizophr Res; 2011 Aug; 130(1-3):137-42. PubMed ID: 21652178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bipolar-ADHD comorbidity: screening for differences in neurocognition and virtual reality-based cognitive performance.
    Jespersen AE; Obel Z; Lumbye A; Kessing LV; Miskowiak KW
    Nord J Psychiatry; 2024 Apr; 78(3):238-246. PubMed ID: 38294688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and cognitive factors affecting psychosocial functioning in remitted patients with bipolar disorder.
    Konstantakopoulos G; Ioannidi N; Typaldou M; Sakkas D; Oulis P
    Psychiatriki; 2016; 27(3):182-191. PubMed ID: 27837572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing cognitive screenings for outpatients with bipolar disorder following optimised treatment in a specialised mood disorder clinic.
    Miskowiak KW; Roikjer TK; Mariegaard J; Bech JL; Obel ZK; Vejstrup B; Hansen L; Kessing LV
    Eur Neuropsychopharmacol; 2024 Jul; 84():27-34. PubMed ID: 38643698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians.
    Miskowiak KW; Burdick KE; Martinez-Aran A; Bonnin CM; Bowie CR; Carvalho AF; Gallagher P; Lafer B; López-Jaramillo C; Sumiyoshi T; McIntyre RS; Schaffer A; Porter RJ; Purdon S; Torres IJ; Yatham LN; Young AH; Kessing LV; Vieta E
    Bipolar Disord; 2018 May; 20(3):184-194. PubMed ID: 29345040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder.
    Guilera G; Pino O; Gómez-Benito J; Rojo JE; Vieta E; Tabarés-Seisdedos R; Segarra N; Martínez-Arán A; Franco M; Cuesta MJ; Crespo-Facorro B; Bernardo M; Purdon SE; Díez T; Rejas J;
    Health Qual Life Outcomes; 2009 Apr; 7():28. PubMed ID: 19338661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validation of the Cognitive Impairment in Psychiatry (SCIP-S) Screen Scale in Patients with Bipolar Disorder I].
    Castaño Ramírez OM; Martínez Ramírez YA; Marulanda Mejía F; Díaz Cabezas R; Valderrama Sánchez LA; Varela Cifuentes V; Aguirre Acevedo DC
    Rev Colomb Psiquiatr; 2015; 44(1):20-7. PubMed ID: 26578215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S).
    Rojo E; Pino O; Guilera G; Gómez-Benito J; Purdon SE; Crespo-Facorro B; Cuesta MJ; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Mesa F; Rejas J;
    Schizophr Res; 2010 Feb; 116(2-3):243-51. PubMed ID: 19744832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Italian Validation of the Screen for Cognitive Impairment in Psychiatry.
    Belvederi Murri M; Folesani F; Costa S; Morelli AC; Scillitani V; Guaiana G; Biancosino B; Caruso R; Nanni MG; Zerbinati L; Purdon SE; Grassi L
    Community Ment Health J; 2020 Nov; 56(8):1411-1418. PubMed ID: 32076904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for cognitive impairment among patients with work-related stress complaints in Denmark: validation and evaluation of objective and self-report tools.
    Jensen JH; Miskowiak KW; Purdon SE; Thomsen JF; Eller NH
    Scand J Work Environ Health; 2022 Jan; 48(1):71-80. PubMed ID: 34580738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients.
    Gómez-Benito J; Guilera G; Pino Ó; Rojo E; Tabarés-Seisdedos R; Safont G; Martínez-Arán A; Franco M; Cuesta MJ; Crespo-Facorro B; Bernardo M; Vieta E; Purdon SE; Mesa F; Rejas J;
    BMC Psychiatry; 2013 May; 13():127. PubMed ID: 23648193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there an association between subjective and objective measures of cognitive function in patients with affective disorders?
    Svendsen AM; Kessing LV; Munkholm K; Vinberg M; Miskowiak KW
    Nord J Psychiatry; 2012 Sep; 66(4):248-53. PubMed ID: 22070515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
    Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E
    Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive remediation versus active computer control in bipolar disorder with psychosis: study protocol for a randomized controlled trial.
    Lewandowski KE; Sperry SH; Ongur D; Cohen BM; Norris LA; Keshavan MS
    Trials; 2016 Mar; 17(1):136. PubMed ID: 26969299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of subjective and objective cognitive function in bipolar disorder: Correlations, predictors and the relation to psychosocial function.
    Demant KM; Vinberg M; Kessing LV; Miskowiak KW
    Psychiatry Res; 2015 Sep; 229(1-2):565-71. PubMed ID: 26073281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.